Understanding who is initiating therapy provides critical context for how the market may evolve
A new gastric juice peptide, BPC: an overview of the stomach-stress-organoprotection hypothesis
Gut microbiota disruption has the potential to provoke a number of processes, including neuroinflammation, BBB dysfunction, dysregulation in immunity, and new patterns in neurotransmitter metabolism
Its active ingredient is tirzepatide, which is both a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist and a GLP-1 receptor agonist
Parapsilosis ) is a type of fungus that lives on your skin and in your gastrointestinal (GI) tract
Within the treated group, the timing of the GLP-1 stoppage didn't seem to have a huge effect on the results